Mink Therapeutics Inc (INKT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	59.98% 0.0166	0.0415	0.1073	0.1464	0.1681
Operating Expenses	30.59% 3.8465	5.5416	5.3308	6.4897	6.0222
Benefits Costs and Expenses	30.37% 3.8299	5.5001	-	-	5.8541
Costs And Expenses	30.37% 3.8299	5.5001	5.3308	6.4897	5.8541
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	30.37% -3.8299	-5.5001	-5.2236	-6.3433	-5.8541
Net Interest Income/Expense	59.98% 0.0166	0.0415	0.1073	0.1464	0.1681
Interest Income/Expense After Provision For Losses	59.98% 0.0166	0.0415	0.1073	0.1464	0.1681
Income/Loss From Continuing Operations Before Tax	30.14% -3.8133	-5.4586	0.1073	-6.197	-5.686
Income/Loss From Continuing Operations After Tax	30.14% -3.8133	-5.4586	-5.1163	-6.197	-5.686
Net Income/Loss	30.14% -3.8133	-5.4586	-5.1163	-6.197	-5.686
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	51,754% 34.64	0.0668	34.50	34.41	33.97
Diluted Average Shares	51,754% 34.64	0.0668	34.50	34.41	33.97
Basic Earnings Per Share	26.67% -0.11	-0.15	-0.15	-0.18	-0.17
Diluted Earnings Per Share	26.67% -0.11	-0.15	-0.15	-0.18	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%